Menu
×
×

Sign Up

Your Profile will be reviewed by Admin
TODAY : Advance Search
EVENT DATES
Feb 2018
MoTuWeThFrSaSu
   1234
567891011
12131415161718
19202122232425
262728    

Venue

New York Marriott Marquis 1,535 Broadway New York , New York 10036
Tel: (212) 398-1900
Website
Google Map

BIO CEO & Investor Conference 2018 - Biotechnology Industry Organization

$ $975 - $6,850

Overview

Event Overview:

Where biotech's elite engage the Street.

The BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. Because our mission is to support industry-wide success, we present a broad and unbiased view of investment opportunities.

Attendees: 1,400+

Countries Represented: 28

BIO One-on-One Meetings: 2,600+

Registered Investors: 650

Company Presentations: 190

Expert Speakers: 58

About BIO:

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter.”

Agenda

Feb 12   

8:00am - 5:55pm 

Company Presentations

9:00am - 10:15am

Therapeutic Panel
Immuno-Oncology Milestones to Come: Pipelines Beyond CART-T 1.0

10:30pm - 11:25am

Fireside Chat
Jeffrey D. Marrazzo, Co-Founder and Chief Executive Officer, Spark Therapeutics 

12:00pm - 12:55pm

Business Session
The Art of the Exit: Planning for Your Company’s Acquisition

1:00pm - 1:55pm

Business Session
Updating Your China Growth Strategy: Opportunities in Investor and Regulatory Dynamism

2:00pm - 2:55pm

Fireside Chat
Lan Huang, PhD, Co-Founder, Charmain and Chief Executive Officer, BeyondSpring Pharmaceuticals

3:00pm - 3:55pm

Therapeutic Panel
Chronic Disease Innovation: PCSK9 Treatments’ Early Lessons for Other Therapies

4:00pm - 4:55pm

Therapuetic Panel 
Advances in Dermatology: Recent Approvals and Later-Stage Trials 

5:00pm - 5:55pm

Business Session
Market Outlook—How Durable is the IPO Resurgence and M&A Slowdown?

6:00 - 7:00pm

Welcome Reception

Feb 13   

8:00am - 4:25pm

Company Presentations

9:00am - 9:55am

Therapuetic Panel
Neuroscience of Addiction: Levers to Attack the Opioid Abuse Crisis

10:00am - 10:55am

Fireside Chat
Deborah Dunsire, MD, President and Chief Executive Officer, XTuit Pharmaceuticals

11:00am - 11:55pm

Business Session
Policy Outlook—Implications of the Tax Code Priorities of the Trump Administration

12:00pm - 12:55pm

Fireside Chat
Rachel Sherman, MD, MPH, Principal Deputy Commissioner, U.S. Food and Drug Administration (FDA)

1:00pm - 1:55pm

Business Session
Instilling Innovation Ambitions in your Leadership Culture

2:00pm - 2:55pm

Fireside Chat
Vivek Ramaswamy, Founder and Chief Executive Officer, Roivant Sciences

3:00pm - 3:55pm

Business Session
Funding Cures: Prioritizing Policy Barriers to Amortization of Therapeutic Spending

4:00pm - 4:55pm

Fireside Chat
Vicki Sato, PhD, Chairman, Denali Therapeutics; Chairman, Vir Biotechnology

5:00pm - 6:00pm

Closing Reception

SERVICE PROVIDERS

RELATED EVENTS +

MORE events +